William Blair & Company
PACB icon

William Blair & Company’s Pacific Biosciences PACB Stock Holding History

William Blair & Company’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,079
Closed -$349K – 1972
2021
Q4 		$349K Buy
17,079
+3,970
+30% +$95.8K ﹤0.01% 1365
2021
Q3 		$335K Buy
+13,109
New +$388K ﹤0.01% 1303
2017
Q4 		– Sell
-27,811
Closed -$146K – 1427
2017
Q3 		$146K Hold
27,811
– – ﹤0.01% 1285
2017
Q2 		$99K Sell
27,811
-49,300
-64% -$199K ﹤0.01% 1424
2017
Q1 		$389K Hold
77,111
– – ﹤0.01% 985
2016
Q4 		$293K Buy
+77,111
New +$560K ﹤0.01% 1018
2016
Q3 		– Sell
-44,000
Closed -$310K – 1312
2016
Q2 		$310K Buy
+44,000
New +$402K ﹤0.01% 966
2015
Q1 		– Sell
-21,000
Closed -$164K – 2184
2014
Q4 		$164K Hold
21,000
– – ﹤0.01% 1981
2014
Q3 		$103K Buy
+21,000
New +$110K ﹤0.01% 2025

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return